Jon Snodgres Insider Trading $RGEN REPLIGEN CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jon Snodgres.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jon Snodgres. Jon Snodgres is CFO in REPLIGEN CORP ($RGEN) and Chief Financial Officer in REPLIGEN CORP ($RGEN).
Jon Snodgres in REPLIGEN CORP
Trading Symbol: RGENIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jon Snodgres: Chief Financial Officer, CFO
Holdings: 31,893 shares
Current Value: $932,551
Latest Transaction: May 18 2021
$RGEN Market Capitalization: $984.14M
$RGEN Previous Close: $29.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Jon Snodgres in REPLIGEN CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 18 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 172.60 | 470 | 81,122 | 31,893 | 32.4 K to 31.9 K (-1.45 %) |
Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 189.75 | 600 | 113,850 | 32,363 | 33 K to 32.4 K (-1.82 %) |
Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 190.45 | 603 | 114,841 | 32,963 | 33.6 K to 33 K (-1.80 %) |
Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 191.43 | 500 | 95,715 | 33,566 | 34.1 K to 33.6 K (-1.47 %) |
Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 192.54 | 900 | 173,286 | 34,066 | 35 K to 34.1 K (-2.57 %) |
Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 193.72 | 242 | 46,880 | 34,966 | 35.2 K to 35 K (-0.69 %) |
Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 196.30 | 500 | 98,150 | 35,208 | 35.7 K to 35.2 K (-1.40 %) |
Mar 08 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 197.86 | 200 | 39,572 | 35,708 | 35.9 K to 35.7 K (-0.56 %) |
Feb 26 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | A | 215.58 | 2,910 | 627,338 | 2,910 | |
Feb 26 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 2,410 | 0 | 35,908 | 33.5 K to 35.9 K (+7.19 %) |
Jan 26 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | M | 33.87 | 4,000 | 135,480 | 6,887 | |
Jan 26 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Buy | M | 33.87 | 4,000 | 135,480 | 33,498 | 29.5 K to 33.5 K (+13.56 %) |
Jan 06 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 195.77 | 59 | 11,550 | 29,498 | 29.6 K to 29.5 K (-0.20 %) |
Jan 06 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 195.16 | 571 | 111,436 | 29,557 | 30.1 K to 29.6 K (-1.90 %) |
Jan 06 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 193.88 | 218 | 42,266 | 30,128 | 30.3 K to 30.1 K (-0.72 %) |
Jan 06 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 192.74 | 918 | 176,935 | 30,346 | 31.3 K to 30.3 K (-2.94 %) |
Jan 06 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 190.50 | 202 | 38,481 | 31,264 | 31.5 K to 31.3 K (-0.64 %) |
Jan 06 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 190.09 | 1,333 | 253,390 | 31,466 | 32.8 K to 31.5 K (-4.06 %) |
Jan 06 2021 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 188.69 | 656 | 123,781 | 32,799 | 33.5 K to 32.8 K (-1.96 %) |
May 19 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 140.43 | 660 | 92,684 | 32,267 | 32.9 K to 32.3 K (-2.00 %) |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | M | 32.40 | 9,024 | 292,378 | 3,086 | |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | M | 26.05 | 3,170 | 82,579 | 0 | |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 132.37 | 846 | 111,985 | 32,927 | 33.8 K to 32.9 K (-2.50 %) |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 131.38 | 3,013 | 395,848 | 33,773 | 36.8 K to 33.8 K (-8.19 %) |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 130.20 | 1,700 | 221,340 | 36,786 | 38.5 K to 36.8 K (-4.42 %) |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 128.70 | 1,612 | 207,464 | 38,486 | 40.1 K to 38.5 K (-4.02 %) |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 127.75 | 2,865 | 366,004 | 40,098 | 43 K to 40.1 K (-6.67 %) |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 126.77 | 5,358 | 679,234 | 42,963 | 48.3 K to 43 K (-11.09 %) |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Buy | M | 32.40 | 9,024 | 292,378 | 48,321 | 39.3 K to 48.3 K (+22.96 %) |
May 15 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Buy | M | 26.05 | 3,170 | 82,579 | 39,297 | 36.1 K to 39.3 K (+8.77 %) |
Mar 05 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 90.39 | 1,045 | 94,458 | 36,127 | 37.2 K to 36.1 K (-2.81 %) |
Mar 05 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 88.18 | 610 | 53,790 | 37,172 | 37.8 K to 37.2 K (-1.61 %) |
Mar 02 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | A | 44.13 | 4,571 | 201,718 | 4,571 | |
Mar 02 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 4,686 | 0 | 37,782 | 33.1 K to 37.8 K (+14.16 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 86.11 | 946 | 81,460 | 31,096 | 32 K to 31.1 K (-2.95 %) |
Feb 27 2020 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 86.86 | 154 | 13,376 | 32,042 | 32.2 K to 32 K (-0.48 %) |
Dec 09 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | M | 26.05 | 1,957 | 50,980 | 3,170 | |
Dec 09 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | M | 24.50 | 2,000 | 49,000 | 0 | |
Dec 09 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Buy | M | 26.05 | 1,957 | 50,980 | 32,196 | 30.2 K to 32.2 K (+6.47 %) |
Dec 09 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Buy | M | 24.50 | 2,000 | 49,000 | 30,239 | 28.2 K to 30.2 K (+7.08 %) |
Jul 17 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Payment of Exercise | F | 85.95 | 295 | 25,355 | 28,239 | 28.5 K to 28.2 K (-1.03 %) |
May 15 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 8,000 | 0 | 28,534 | 20.5 K to 28.5 K (+38.96 %) |
Mar 27 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 59.05 | 1,009 | 59,581 | 20,534 | 21.5 K to 20.5 K (-4.68 %) |
Mar 27 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 58.45 | 5,458 | 319,020 | 21,543 | 27 K to 21.5 K (-20.21 %) |
Mar 05 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 58.52 | 2,645 | 154,785 | 27,001 | 29.6 K to 27 K (-8.92 %) |
Mar 05 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 4,700 | 0 | 29,646 | 24.9 K to 29.6 K (+18.84 %) |
Mar 04 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | A | 59.52 | 5,653 | 336,467 | 5,653 | |
Mar 04 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 58.88 | 1,875 | 110,400 | 24,946 | 26.8 K to 24.9 K (-6.99 %) |
Mar 04 2019 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 5,922 | 0 | 26,821 | 20.9 K to 26.8 K (+28.34 %) |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Option Exercise | M | 26.05 | 10,253 | 267,091 | 5,127 | |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Option Exercise | M | 32.40 | 6,055 | 196,182 | 12,110 | |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Option Exercise | M | 24.50 | 4,000 | 98,000 | 2,000 | |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Option Exercise | M | 26.20 | 11,445 | 299,859 | 0 | |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Sell | S | 63.49 | 31,753 | 2,015,915 | 20,899 | 52.7 K to 20.9 K (-60.31 %) |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Buy | M | 26.05 | 10,253 | 267,091 | 52,652 | 42.4 K to 52.7 K (+24.18 %) |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Buy | M | 32.40 | 6,055 | 196,182 | 42,399 | 36.3 K to 42.4 K (+16.66 %) |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Buy | M | 24.50 | 4,000 | 98,000 | 36,344 | 32.3 K to 36.3 K (+12.37 %) |
Nov 28 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Buy | M | 26.20 | 11,445 | 299,859 | 32,344 | 20.9 K to 32.3 K (+54.76 %) |
Aug 29 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Sell | S | 52.79 | 14,460 | 763,359 | 20,899 | 35.4 K to 20.9 K (-40.89 %) |
Jul 20 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Payment of Exercise | F | 47.91 | 295 | 14,134 | 35,359 | 35.7 K to 35.4 K (-0.83 %) |
Mar 05 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Option Exercise | A | 33.87 | 20,659 | 699,720 | 20,659 | |
Mar 05 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Grant | A | 0.00 | 10,680 | 0 | 35,654 | 25 K to 35.7 K (+42.76 %) |
Mar 02 2018 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Payment of Exercise | F | 35.16 | 2,470 | 86,843 | 24,974 | 27.4 K to 25 K (-9.00 %) |
Jul 20 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Payment of Exercise | F | 41.77 | 345 | 14,411 | 27,444 | 27.8 K to 27.4 K (-1.24 %) |
Mar 21 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | M | 24.50 | 4,000 | 98,000 | 6,000 | |
Mar 21 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Buy | M | 24.50 | 4,000 | 98,000 | 27,789 | 23.8 K to 27.8 K (+16.81 %) |
Mar 21 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Sell | S | 34.91 | 1,909 | 66,646 | 23,789 | 25.7 K to 23.8 K (-7.43 %) |
Mar 01 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | A | 32.32 | 19,750 | 638,320 | 19,750 | |
Mar 01 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Payment of Exercise | F | 32.07 | 1,630 | 52,273 | 25,698 | 27.3 K to 25.7 K (-5.96 %) |
Mar 01 2017 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 9,875 | 0 | 27,328 | 17.5 K to 27.3 K (+56.58 %) |
Jul 15 2016 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Payment of Exercise | F | 26.56 | 324 | 8,605 | 17,453 | 17.8 K to 17.5 K (-1.82 %) |
Mar 01 2016 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Option Exercise | A | 26.05 | 15,380 | 400,649 | 15,380 | |
Mar 01 2016 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Payment of Exercise | F | 26.05 | 748 | 19,485 | 17,777 | 18.5 K to 17.8 K (-4.04 %) |
Mar 01 2016 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Grant | A | 0.00 | 7,905 | 0 | 18,525 | 10.6 K to 18.5 K (+74.44 %) |
Nov 12 2015 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Payment of Exercise | F | 41.30 | 325 | 13,423 | 10,620 | 10.9 K to 10.6 K (-2.97 %) |
Mar 02 2015 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Option Exercise | A | 24.98 | 11,445 | 285,896 | 11,445 | |
Mar 02 2015 | RGEN | REPLIGEN CORP | Snodgres Jon | Chief Financial Off ... | Grant | A | 0.00 | 5,945 | 0 | 10,945 | 5 K to 10.9 K (+118.90 %) |
Jul 15 2014 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Option Exercise | A | 24.50 | 10,000 | 245,000 | 10,000 | |
Jul 15 2014 | RGEN | REPLIGEN CORP | Snodgres Jon | CFO | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Page: 1